AltaSciences
AltaSciences Headquarters Location
Laval, CA
About AltaSciences
AltaSciences is a mid-size contract research organization with a unique focus on supporting drug development from lead candidate selection to proof of concept. With over 25 years of industry experience, we provide preclinical and clinical solutions to an international customer base of biopharmaceutical companies. Our full-service offering in this critical stage of drug development includes program management, preclinical safety testing, clinical pharmacology services, manufacturing and analytical services, medical writing, biostatistics, data management, and bioanalysis services tailored to specific research requirements. AltaSciences has facilities in Montreal, QC; Kansas City, KS, Seattle, WA and Philadelphia, PA.
Our team is made up of over 1,300 professionals from the medical and scientific fields who work together to achieve a common goal: to contribute to the advancement of life sciences.
AltaSciences Preclinical ServicesOur team is made up of over 1,300 professionals from the medical and scientific fields who work together to achieve a common goal: to contribute to the advancement of life sciences.
Leveraging decades of experience conducting safety assessment, AltaSciences offers a full range of in vivo GLP and non-GLP preclinical evaluation studies in multiple species to thoroughly assess the safety profile of your molecules. Working as an extension of your team, our scientists and technicians help you expedite your research goals, ensuring that your preclinical drug development program provides the quality data for key decision making.
Our preclinical drug development offerings feature rigorous attention to your needs, including data integrity, scientific excellence, and a strong focus on animal welfare. Our solutions include IND-enabling and NDA-enabling toxicology, safety pharmacology, and laboratory services that meet global regulatory requirements, for both small and large molecules. Our preclinical and clinical services work hand in hand to ensure a rapid and smooth transition from safety testing to first-in-human trials.
Our preclinical drug development offerings feature rigorous attention to your needs, including data integrity, scientific excellence, and a strong focus on animal welfare. Our solutions include IND-enabling and NDA-enabling toxicology, safety pharmacology, and laboratory services that meet global regulatory requirements, for both small and large molecules. Our preclinical and clinical services work hand in hand to ensure a rapid and smooth transition from safety testing to first-in-human trials.
Number of Employees in AltaSciences
1,001 to 5,000
AltaSciences Revenue
$25M to $100M (USD)
Industry